Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 3/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.38 |
| ▸ | DHFR | P00374 | 3/20 | 0.37 |
| ▸ | BMPR2 | Q13873 | 1/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 6/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 4/20 | 0.36 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3430562 | 0.83 | CHRNA7 (0.56) | CHRNA7KCNH2DHFR | |
| SCHEMBL3431236 | 0.83 | LMNA (0.42) | CHRNA7KCNH2DHFRADORA1ADORA2A | |
| SCHEMBL3433510 | 0.75 | HRH4 (0.52) | — | |
| SCHEMBL3432392 | 0.73 | MAP3K12 (0.52) | — | |
| SCHEMBL19066248 | 0.66 | ADORA1 (0.49) | DHFRADORA1ADORA2A | |
| SCHEMBL3430566 | 0.65 | CHRNA7 (0.57) | CHRNA7KCNH2DHFRADORA1ADORA2A | |
| SCHEMBL2167151 | 0.65 | HRH4 (0.61) | DHFR | |
| SCHEMBL4560009 | 0.65 | HRH4 (0.54) | DHFRADORA1ADORA2A | |
| SCHEMBL4785225 | 0.63 | CHRNA7 (0.51) | CHRNA7KCNH2DHFRPIK3CD | |
| SCHEMBL7708544 | 0.62 | NOS1 (0.58) | DHFRPIK3CDPIK3R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2265607-A1 | PYRIMIDINE-2-AMINE COMPOUNDS AND THEIR USE AS INHIBITORS OF JAK KINASES | Rigel Pharmaceuticals, Inc. (US) | 2010-12-29 | — | — | EP | disclosed |
| WO-2009103032-A1 | PYRIMIDINE-2-AMINE COMPOUNDS AND THEIR USE AS INHIBITORS OF JAK KINASES | RIGEL PHARMACEUTICALS, INC. (US) | 2009-08-20 | — | — | WO | disclosed |